NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: M
Post# of 174
(Total Views: 212)
Posted On: 05/05/2020 3:38:15 PM
NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report
Trxade Group Inc. (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We reiterate our Buy rating and $12 Price Target on MEDS following Q1 results that beat expectations. As the only estimate on the Street, we note that revenue, EBITDA and EPS were each ahead of our forecast. MEDS added 305 new pharmacy registrations which was in line with our forecast of 300. We were pleased also with the “same-store” growth of pharmacy prescription volume which was up 14% y/y and drove the upside to our model. Results were especially strong in light of the COVID pandemic which impacted results in the last 3 weeks of March. We are increasing estimates for 2020 and continue to recommend the name.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Trxade Group Inc. (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We reiterate our Buy rating and $12 Price Target on MEDS following Q1 results that beat expectations. As the only estimate on the Street, we note that revenue, EBITDA and EPS were each ahead of our forecast. MEDS added 305 new pharmacy registrations which was in line with our forecast of 300. We were pleased also with the “same-store” growth of pharmacy prescription volume which was up 14% y/y and drove the upside to our model. Results were especially strong in light of the COVID pandemic which impacted results in the last 3 weeks of March. We are increasing estimates for 2020 and continue to recommend the name.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)